J&J agrees to pay drug import fine
Johnson & Johnson will pay more than $500,000 in fines after the federal government found that the company did not adhere to the Controlled Substances Act when it failed to report the importation of medications.
- Sharp HealthCare Leaves Pioneer ACO Program
- Acute Kidney Injury Gets New Focus
- CNO Leads $1M Charge for New Scrubs, Uniforms
- MA an Insurance Proving Ground for Providers
- Interventional Radiology No Longer a Sub-Specialty
- Targeting Self-Insured Populations
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- States Without Medicaid Expansion Search for Alternatives
- mHealth Tackles Readmissions